【SCI专题】SCI文章投稿格式
sci论文格式要求
![sci论文格式要求](https://img.taocdn.com/s3/m/da0b337f302b3169a45177232f60ddccda38e6ac.png)
sci论文格式要求sci论文格式要求SCI论文是被SCI索引收录的期刊所刊登的论文,目前我国科技界对SCI论文概念模式,小部分研究者误认为SCI是一本期刊,由南京大学引用并成为各大高校和科研机构学术评价和奖惩的一类刊物。
下面,小编为大家分享sci论文格式要求,希望对大家有所帮助!前置部分包括①题目(title);②作者(单位及/或个人姓名);③内容摘要(Summary);④关键词(keywords)。
主题部分包括⑤前言(introduction);⑥材料与方法(materi-alsandmethods);⑦结果(results);⑧讨论(disscussion);⑨结论(conclusion);⑩致谢(thanks)、参考文献(references)、完成论文或投稿日期、外文摘要。
附录部分包括图(chart)、表(table)、照片(photoshop)等。
格式并非一成不变,作者应根据文稿的内容、体裁及篇幅的长短撰写,切记不要硬套格式。
篇幅小的论文,可将前言、材料与方法两项合并,讨论与结论合并,并省去“内容摘要(Summary)”.有协作关系或得到有关单位个人支持帮助的,要在首页注脚处加一项“致谢(thanks)”.SCI论文字体、段落格式纸张大小标准的8.5英寸x11英寸纸张大小页边距上下左右页边距都为1寸英字体12号字体大小。
Times Roman. 但是图片使用无衬线字体,如Arial行距两倍行距对齐方式左对齐(右边距不相等)段落缩进5 - 7个空格句末句号后一个空格页码标题页开始,除图片页外每一页的`右上角,离顶部0.5英寸处标上页码,右对齐。
标题页标题页通常是第一页。
在页码下一行,副标题左对齐,副标题要全部大写。
在副标题下,使用大写和小写表示以下内容,居中对齐。
文章标题你的名字你所属的机构信息段落标题一级标题使用大小写字母,并且居中。
二级标题使用大小写字母,左对齐。
表和插图除非期刊有特别要求,除此之外,表和插图放在文章的最后。
有关SCI论文发表的通用格式你知道吗
![有关SCI论文发表的通用格式你知道吗](https://img.taocdn.com/s3/m/d9fa6c1652ea551810a687f9.png)
有关SCI论文发表的通用格式你知道吗?论文发表是每个毕业生在学生生涯中非常重要的事情,但是有关SCI论文发表的通用格式你知道吗?下面就针对这一点给广大毕业生们分享一些经验,供大家参考。
标题(三号宋体,居中,加粗)【说明:标题是能反映论文中特定内容的恰当、简明的词语的逻辑组合,应避免使用含义笼统、泛指性很强的词语(一般不超过20字,必要时可加副标题,尽可能不用动宾结构,而用名词性短语,也不用“……的研究”,“基于……”)】作者11,作者21,作者31……(四号楷体,居中)(1. 学校院、系名,省份城市邮编;2. 单位名称,省份城市邮编)(五号楷体,居中)摘要:(小五号黑体,缩进两格)摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容摘要内容……(小五号楷体)【说明:摘要应具有独立性和自含性,即不阅读全文,就能获得必要的信息。
要使用科学性文字和具体数据,不使用文学性修本人系天天论文网就职11年的资深论文编辑;工作中与各大医学期刊杂志社进行学术交流过程中建立了稳定的编辑朋友圈,系多家医学杂志社的特约编辑,常年为医学期刊杂志供稿,负责天天论文网医学论文·分检·编校·推送·指导等工作!工作企鹅1:1550116010工作企鹅2:766085044饰词;不使用图、表、参考文献、复杂的公式和复杂的化学式,非公知公用的符号或术语;不要加自我评价,如“该研究对…有广阔的应用前景”,“目前尚未见报道”等。
摘要能否准确、具体、完整地概括原文的创新之处,将直接决定论文是否被收录、阅读和引用。
摘要长度200~300字。
摘要一律采用第三人称表述,不使用“本文”、“文章”、“作者”、“本研究”等作为主语。
】关键词:(小五号黑体,缩进两格)关键词;关键词;关键词;关键词(小五号楷体,全角分号隔开)【说明:关键词是为了便于作文献索引和检索而选取的能反映论文主题概念的词或词组,每篇文章标注3~8个关键词,词与词之间用全角分号隔开。
Elsevier(SCI) 投稿要求翻译总结
![Elsevier(SCI) 投稿要求翻译总结](https://img.taocdn.com/s3/m/61f2c9c958f5f61fb7366623.png)
Elsevier(SCI) 投稿要求翻译总结1. 正规文章:5000-7000字;2. 文本应为:(1)单栏格式。
文本布局尽可能简单;(2)不要使用文字处理软件的自带选项来调整文本或者断字功能(应该就是对齐和换行的时候的设定问题);(3)可以使用加粗、斜体、下标,上标等;(4)不要把公式和表格做成图片格式放到文本中,而是使用文字处理软件的自带功能(诸如表格功能和公式编辑器);(5)当制表时,不要画竖线,每列只有一个横线隔断(应该就是我们常用的三横线表格);(6)一般是双倍行距,font11或12也就是小四号字。
图和表单独放在文尾的位置(来自其他网络)3.结构安排:表1.1 ;1.1.1;1.1.2等等。
使用这个编码也是为了内部的交叉参考,如见“1.2”而不能写成“见本文”。
任何的次级部分都要有一个简短的标题;每个标题都应当单独起行。
4. 缩写:在这个领域中不是标准常见的缩写需要给出定义,以脚注的形式在文章中的第一页。
这样的缩写应当避免出现在摘要中,如果出现了需要马上给出定义,并同时需要标在脚注中。
确保所有的缩写在整篇文章中的统一性。
5. 致谢:应出现在文章最后的部分,在参考文献之前,不要把这些作者包含在题目页中,不要以脚注或其他的形式出现。
列出这些个人对研究的支持,例如包括提供了语言帮助,写作协助,或者提供阅读服务e.g., providing language help, writing assistance or proof reading the article, etc.6. 单位:按照国际公认的规则和惯例:使用国际单位制(SI)。
如果提到其他单位,请给出他们和SI之间的当量关系。
7. 公式:简单的公式放在正常文本的一行内,使用斜杠代替水平的直线,例如X/Y;按照原则,变量应当用斜体表示出来;e的n次方一般用exp表示;如果有的公式不能当成文本放置在文字中,应该作为单独一行列写,并进行编号。
SCI投稿全过程信件模板一览来源
![SCI投稿全过程信件模板一览来源](https://img.taocdn.com/s3/m/b34ea07a86c24028915f804d2b160b4e777f815d.png)
SCI投稿全过程信件模板一览来源
我希望以此信函向贵刊投稿,并希望获得贵刊对于我研究成果的评估和发表机会。
我是一名从事(研究领域)的研究人员,目前所研究的主题与贵刊的专业领域高度契合,因此我相信我的研究成果将对贵刊的读者具有重要的学术意义。
以下是我对于投稿的全过程信件模板,请您查阅:
1. 封面信(Cover Letter)
假如您对于我研究的兴趣颇高并愿意鉴定我的研究成果,请写这个关于封面信。
简要地介绍投稿的目的和研究的背景,并强调研究的重要性和新颖性。
同时,特别指出为何我选择贵刊投稿以及希望获得发表与评估的机会。
2. 摘要页(Abstract)
3. 介绍(Introduction)
4. 方法(Methods)
5. 结果(Results)
6. 讨论(Discussion)
7. 结论(Conclusion)
8. 致谢(Acknowledgements)
最后,我衷心希望贵刊能够考虑我的投稿,并给予我一个发表研究成果的机会。
我相信我的研究成果将对贵刊的学术质量和影响力有所提升。
非常感谢您的时间和关注。
顺祝商祺。
衷心。
SCI 投稿全过程信件模板一览
![SCI 投稿全过程信件模板一览](https://img.taocdn.com/s3/m/91d580c576eeaeaad1f3303b.png)
SCI 投稿全过程信件模板一览一、最初投稿Cover letterDear Editors:We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, a nd manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed.In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”.The following is a list of possible reviewers for your consideration:1) Name A E-mail: ××××@××××2) Name B E-mail: ××××@××××We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address belo w.Thank you and best regards.Yours sincerely,××××××Corresponding author:Name: ×××E-mail: ××××@××××二、催稿信Dear Prof. ×××:Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manus cript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript has been sent to reviewers or not?I would be greatly appreciated if you could spend some of your time check the status for us. I am very pleased to hear from you on the reviewer’s comments.Thank you very much for your consideration.Best regards!Yours sincerely,××××××Corresponding author:Name: ×××E-mail: ××××@××××三、修改稿Cover letterDear Dr/ Prof..(写上负责你文章编辑的姓名,显得尊重,因为第一次的投稿不知道具体负责的编辑,只能用通用的Editors):On behalf of my co-authors, we thank you very much for giving us an opportunity to revise our manuscript, we appreciate editor and reviewers very much for their positive and constructive comments and suggestions on our manuscript entitled “Paper Title”. (ID: 文章稿号).We have studied reviewer’s comments carefully and have made revision which marked in red in the paper. We have tried our best to revise our manuscript according to the comments. Attached please find the revised version, which we would like to submit for your kind consideration.We would like to express our great appreciation to you and reviewers for comments on our paper. Looking forward to hearing from you.Thank you and best regards.Yours sincerely,××××××Corresponding author:Name: ×××E-mail: ××××@××××四、修改稿回答审稿人的意见(最重要的部分)List of ResponsesDear Editors and Reviewers:Thank you for your letter and for the reviewers’ comments concerning our manuscript entitled “Paper Title” (ID: 文章稿号). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. We have studied comments carefully and have made correction which we hope meet with approval. Revised portion are marked in red in the paper. The main corrections in the paper and the responds to the reviewer’s comments are as flowing:Responds to the reviewer’s comments:Reviewer #1:1. Response to comment: (……简要列出意见……)Response: ××××××2. Response to comment: (……简要列出意见……)Response: ××××××。
英文SCI论文发表各步英文信模板
![英文SCI论文发表各步英文信模板](https://img.taocdn.com/s3/m/286a7d7d482fb4daa58d4b8a.png)
英文SCI论文发表各步英文信模板1. 上传或写信或发 E\mail 投递Dear Prof. xxx (Editor):Attached (Enclosed) please find the word or PDF version of my paperentitled "xxx" with the kind request to consider it for publication in the journal xxx.The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere. Should you receive the paper, please send me a e\mail to confirm receipt of it.Thanks a lot in advance! Sincerely, yours2. 收到中期决定一般情况下,收到编辑部的来信,让作者根据审稿人的意见修改,并且在意见中看到审稿人推荐该文章发表,就成功了一大半。
例:I want to take this opportunity to inform you that Peter will be joining us shortly.He has worked in this field for twelve years and we are delighted that he has decided to join our company at this stage of our development.Dear Mr. xxx,Your manuscript, referenced above, has now been reviewed and the reviewer (s) have made suggestions which the Editor feels would Improve your manuscript.however, a friend of mine introduced me to abc company, and i have decided to accept a post that will give me greater possibilities for promotion and an increase in my salary. i therefore write this memo as formal notice to terminate(终止) my engagement with you one month from todays date.The Editor encourages you to consider these comments and make an appropriate revision of your manuscript. The reviewer (s)‘ comments are below.Please submit your revision online within 4 weeks by logging onto the Elsevier Editorial System for the Journal of Applied Psychology.学校名称:美国杜克大学(德汉姆)Duke University (Durham)所在位置:美国,学校设置类型:综合性大学创建时间:1838年学历:语言专科本科研究生网络课程学校性质:私立学生人数:12991人院校地址:2138 Campus Drive Durham, NC 27708 (919) 684-8111The manuscript is now listed under "Submissions Needing Revisions." Click "Revise" when you are ready to submit your revision.The decision was a difficult one for me because I have so enjoyed my working relationships here. The job description has given me great latitude in assisting other coordinators within the human resource area, and as a result, I’ve gained skills in several related fields. These cross-training opportunities have been invaluable, and in a much more formal, classroom setting, I’ve been able to take advantage of classes in management, interpersonal skills, writing, and oral presentations. All of this training has been a worthwhile effort for both AAA (company) and me.Please include a cover letter that addresses the issues raised in the below comments, point by point. You should also include a suitable rebuttal to any specific request for change that has not been made.Thank you, and we look forward to receiving your revised manuscript. With kind regards,3. 修改后再次上传Ms. No.: xxx Title: xxx Corresponding Author: xxx Authors: xxx Dear Editor:My manuscript, referenced above, has been revised according to the reviewer (s)’ comments.I list the modifications as follows:(1).. (2).. (3)... We would like to thank the reviewer (s) for introducing the above literature to us. This isvery helpful to ourfuture study. If there are other errors or further requests, pleasecontact me by e\mail.Sincerely, yours4. 收到最终决Dear Mr. xxx,We are pleased to inform you that your manuscript referenced above has been accepted for publication in the Journal xxx.Many thanks for submitting your fine paper to thexxx. We look forward to receiving additional papers from you in the future.With kind regards, xxx Associate Editor(1)审题准确把握辩题内涵和外延,对所持立场能多层次、多角度理解,论点鲜明,对本方难点能有效处理和化解。
SCI论文发表格式模板[Word文档]
![SCI论文发表格式模板[Word文档]](https://img.taocdn.com/s3/m/ca8fc0f90875f46527d3240c844769eae009a361.png)
SCI论文发表格式模板本文档格式为WORD,感谢你的阅读。
最新最全的学术论文期刊文献年终总结年终报告工作总结个人总结述职报告实习报告单位总结演讲稿SCI论文发表格式模板目前我国科技界对SCI论文概念模式,小部分研究者误认为SCI是一本期刊,而由于南京大学率先引用并愈来愈成为各大高校和科研机构学术评价和奖惩的一类刊物,以下是SCI格式模板,供大家阅读查看。
AbstractAbstract:整体要求简练,言简意赅,因为绝大部分journal对Abstract都有字数限制,一般150~250 words。
先简单描述一下自己工作的前沿背景,几句话,然后引出自己的实验(“In this paper….”; “Herein...” or “Here, we…”),主要陈述实验结果,可稍带提一下所用到的重要方法的名称,然后说明你的结果的意义“There data suggest….”;最后总结拔高“In a word….”or “in summary…..”。
摘要中谓语动词的时态基本上分一般现在时和一般过去时两种。
由于科研通常采用一般现在时,所附摘要自然也多用一般现在时态。
(1) 叙述研究方法和目的时,使用一般现在时态。
A. This article sets out four of the main misconcepts, discusses why they have arisen, and why they can be so described.B. To answer this, the author explores two new algorithms:a.keep in the cache documents that take the longest to retrieve; and e a hybrid of several factors…(2)推导研究结果时用一般现在时态。
A.The results show that the period of induction and the patent period of stressor can be initially confirmed by the electrical conductivity of medium and the variability of soluble protein in tomato.B.A method for stiffness calculation undervertical load is devised.(3) 回顾研究过程时,用一般过去时态。
sci投稿信范文
![sci投稿信范文](https://img.taocdn.com/s3/m/a1f53db9c9d376eeaeaad1f34693daef5ff71354.png)
当撰写SCI期刊的投稿信时,需要遵循特定的格式和要求。
以下是一个范本。
[Your Address][City, Postal Code][Your Email Address][Date]Editor-in-Chief,[Journal Name][Journal Address]Dear Editor,I am writing to submit our manuscript entitled "Title of Your Paper" for consideration for publication in [Journal Name].The research presented in this manuscript explores [Briefly describe the purpose and significance of your study]. Our study employs [Research Methodology] and yields significant findings in the area of [Field/Area].We believe that the findings of our study hold importance for [Explain the relevance of your research].Enclosed, please find our manuscript and accompanying materials for your review. We confirm that this submission is original work and has not been published elsewhere or under consideration for publication elsewhere.Thank you for considering our submission. We look forward to your response.Sincerely,[Your Name][Your Contact Information]请确保根据目标期刊的要求进行适当的修改和调整,例如在方括号中填入具体信息,并在投稿时注意附上实际的论文稿件和相关材料。
SCI论文投稿过程所有信件格式(投稿、催稿、申诉、校样、感谢、审稿)
![SCI论文投稿过程所有信件格式(投稿、催稿、申诉、校样、感谢、审稿)](https://img.taocdn.com/s3/m/5fe6a63cee06eff9aef8072e.png)
生物医学论文投稿、修回、校样及发表相关事宜信件模板及实例美捷登编写2010年10月版权所有,转贴请注明来源DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisTable of Contents投稿信(Cover letter) (3)催稿信(Reminder letter) (5)回复信(Reply/Response Letter) (6)申诉信(Appeal letter) (12)延时修回申请信(Request for extension of the deadline) (14)作者顺序更改信(Author Change Request Letter) (16)费用减免申请信(Concession Request Letter) (17)撤稿申请信(Withdrawal Request Letter) (19)给作者全文索取信(Reprint Request Letter to Author) (20)作者职责、版权转让及利益冲突声明样本(Examples for Authors Responsibility and Copyright Transfer, Declaration of Conflict of Interest) (21)例一 Journal of Clinical Gastroenterology (21)例二 Cancer (22)例三 Gastroenterology (25)例四 Alimentary Pharmacology & Therapeutics (26)例五 Drug Safety (28)校样及单行本订单样本(Examples for Proofs and Reprint Order Form) (31)例一Alimentary Pharmacology & Therapeutics (31)例二 Cancer (31)DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this投稿信(Cover letter)(Please delete the annotations in italic in the parentheses.)Editorial Office,XXXXXXX (Address of the Editorial Office)October 21, 2010 (for an American journal)21 October 2010 (for a British or European Journal)Dear Editor,We would like to submit an original (or a review) article entitled “XXXX (title of the article) for consideration for publication in XXXX (name of the journal).(You may use one paragraph to summarize the significance or merits of the present study here.)This article has not been published elsewhere in whole or in part. All authors have read and approved the content, and agree to submit for consideration for publication in the journal. There are no any ethical/legal conflicts involved in the article.This manuscript has been edited and proofread by Medjaden Bioscience Limited.Your consideration for this manuscript is highly appreciated.DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisLooking forward to hearing from you soon.With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorE-mail:DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this催稿信(Reminder letter)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Re: Ms# XXXX (number of the manuscript if any) – XXXX (title of the article)The abovementioned manuscript has been submitted (or re-submitted) for over X (3 for submission,2 for re-submission) months, but I have not heard of any decision from the journal.I will be most grateful if you could let me know the current status of the manuscript.Please also advise if you need any additional information for the manuscript.Thank very much for your consideration, and look forward to hearing from you soon.With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this回复信(Reply/Response Letter)美捷登主编在丁香园谈如何回复编辑和审稿人(暨友情修改回复信)/bbs/topic/13723128?tpg=1&age=0(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Thank you very much for your letter and advice. We have revised the manuscript, and would like to re-submit it for your consideration. We have addressed the comments raised by the reviewers, and the amendments are highlighted in red in the revised manuscript. Point by point responses to the reviewers’ comments are listed below this letter.This manuscript has been edited and proofread by Medjaden Bioscience Limited.We hope that the revised version of the manuscript is now acceptable for publication in your journal.I look forward to hearing from you soon.With best wishes,Yours sincerely,XXXX (name of the corresponding author)DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisXXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisWe would like to express our sincere thanks to the reviewers for the constructive and positive comments.Replies to Reviewer 1Specific Comments1. JNK2 mRNA levels are relatively higher in SW1116 cells, COLO205 and AGS cells, when compared to the other cell lines tested. However, Similarly JNK proteins levels are high in the three cell lines. However, is low in SW1116 cells, compared to the other two. In addition, the SP compound induced higher levels of apoptosis in AGS and COLO205 cells. It seems that inhibition of phosphorylated JNK may be the mechanism by which the SP compound is acting in these cells. The authors should discuss this potential possibility in the Discussion section.Answer: Several sentences have been changed in the Discussion (page 12, paragraph 1) in the revised version to address this issue.2. The author should mention why they chose the six cell lines for their study.Answer: AGS, HT-29 and COLO205 are widely used gastrointestinal cell lines for MAPK pathway study. And the rest three cell lines are commonly investigated in our Lab.3. Surprisingly, inhibition of MKN-45 cell proliferation did not occur until 72 h. Could this be due to slower growth of the cells in the first place?Answer: Actually, we didn’t find MKN-45 cell grow obviously slower than the other cell lines in our study.DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this4. In the studies with the caspase inhibitor, the authors have only mentioned their results in COLO205. It would be expected that a similar result would have been obtained for AGS cells as well. If so, for the sake of completeness of the report they could add a line stating so.Answer: The statement of AGS has been added in Results (page 10, paragraph 1, line 4) in the revised version.Additional Minor Comments:Materials and Methodsa. 2.1 Cell cultures.-In the first line, MKN-45 cell line is not stated.Answer: MKN-45 has been added in the revised version.b. 2.4 Detection of Caspase-3 activity- typographical error -pH (line 10)Answer: Correction has been made in the revised version.ResultsFirst line- page 10 typographical error- caspase-9Answer: Correction has been made in the revised version (page 10, paragraph1, line7).Referencesa. In ref 6, there is a typographical error, the year is not bracketted and volume is switched. Answer: Correction has been made in the revised version.DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisb. In ref 23. There is a space after journal name.Answer: Correction has been made in the revised version (ref 24).Replies to Reviewer 2Minor considerations:1. Can the authors describe clearly the relations between phosphorylated JNK p38 p54, p56 and JNK1 and JNK2, and the significance of their expression?Answer: Several sentences have been added in the Introduction (page 3, paragraph 1) and Results (page 8, paragraph 3 and page 9, paragraph 1) in the revised version to address this issue.2. The experiments are extensive in the present study. However, the author may wish to perform a further functional study to prove that the differential response in cells to SP-600125 is associated with their basal JNK2 expression.Answer: Yes, further functional study will be conducted to prove the correlation between basal JNK2 expression and cell response to SP-600125, eg. transfection of JNK2 siRNA or antisense.3. There appear some illegal symbols, such as "20?, 37?, etc" in the Methods section.Answer: Corrections have been made in the revised version.4. It is unclear why the author chose to use the dose of 20然 of SP-600125 for treatment of all cancer cell lines. It is recommended that the authors shows a dose response curve for the different cell lines.DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisAnswer: Hideshima T et. al state in their paper “Biologic sequelae of c-Jun NH2-terminal kinase (JNK) activation in multiple myeloma cell lines” that SP600125 inhibits cell growth in a dosage dependent manner (2.5~20uM) in myeloma cell lines. SP600125 20uM in our experiment were found effectively exert its inhibitory effect without cytotoxicity. This reference has been quoted as ref.16 in the revised version.5. Figure 3 would be improved by including the distribution of all phases of the cell cycle (e.g. G0/G1, G2/M and S phase).Answer: The phases of the cell cycle distribution of AGS and COLO205, the two most responsive cell lines with or without treatments, have been listed in Table-1. The G2/M arrest data have been highlighted.6. The results of apoptosis should be included in table 1.Answer: Since apoptosis is not routinely assessed by single PI staining, we used double staining with Annexin V and PI to detect apoptosis more sensitively. The result was shown in Fig.3.7. Page 11 line 5, "SP-600125 induced 1.5-4.5 more times apoptotic cells in 4 out of 6 cancer cell lines". The authors should be more specific and provide the raw data for all the cell lines in the results section.Answer: Several sentences have been added in the Results (page 9, paragraph 3; page 10, paragraph 1) to address this issue.DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this申诉信(Appeal letter)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Thank you for your efficient work in processing our manuscript entitled “XXXX (title of the article)” (Manuscript No: XXXX).After we have carefully read the comments from the reviewers, we realize that the major merits of our work were not fully identified or recognized by the reviewers. (If one or more reviewers pointed out the merits of the study, but criticized the language and presentation of the manuscript, then you should state that: After we have carefully read the comments from the reviewers, we realize that the major merits of our work have been identified or recognized by the reviewers. We believe that the major critical issue for our manuscript is the poor preparation of the manuscript, which can be improved by a native speaker or a professional editing company.)Here we would emphasize that the most notable merits of our manuscript include:1)2)3)I had opportunities to talk to Dr. XXX (of XXX University), and Dr. XXX (XXX University), and both of them read the manuscript and encourage me to write to you to ask if you could consider a revised version of the manuscript. (this should be included in the letter only if you have done so. Otherwise, this paragraph is not required.).Point-by-point responses to the reviewers’ comments are enclosed after the letter for your consideration.In addition, this manuscript has been edited and proofread by Medjaden Bioscience Limited. DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisI will be most grateful if you could offer us a second opportunity (or an additional opportunity if the rejected manuscript is already a revised one).Look forward to hearing from you soon,With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorWe would like to express our sincere thanks to the reviewers for the constructive and positive comments.Replies to Reviewer 1XXXX (Point by point responses to the comments of reviewer 1).Replies to Reviewer 2XXXX (Point by point responses to the comments of reviewer 2).DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this延时修回申请信(Request for extension of the deadline)(Please delete the annotations in italic in the parentheses.)Editorial OfficeXXXXXXOctober 21, 2010 (for an American journal)21 October 2010 (for a British or European Journal) Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),I am writing you regarding our submitted article entitled “XXXX (title of the article)” (Manuscript No: XXXX), which is currently under revision.Due to my business trip and an annual leave afterwards, I did not read the messages from your editorial office on time. (Or you may have other reasons that may delay the revision process and you should make statement accordingly).Since major revisions are needed for our manuscript, I am afraid that we are not able to re-submit the revised version of the manuscript by the deadline (the date of the current deadline). Therefore, I will be most grateful if you could extend the deadline, preferably, for 2 weeks (or any duration you wish to extend, but better less than 1 month if possible), so that we can revise the manuscript more appropriately.Thank you in advance for your understanding and kind assistance, and look forward to receiving your advice soon.With kind regards,DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisYours sincerely,XXXX (name of the corresponding author)XXXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this作者顺序更改信(Author Change Request Letter)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Re: Ms# XXXX (number of the manuscript if any) – XXXX (title of the article) Therefore, I am writing you to make a change in the order of the authors. We wish to place Dr. XXX in the second place (or wherever you wish). All others have agreed with this change.We hope that this change is acceptable. However, please advise if you have any questions about this change.Thank very much for your consideration.With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this费用减免申请信(Concession Request Letter)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Re: Ms# XXXX (number of the manuscript if any) – XXXX (title of the article)I am very pleased that our paper has been accepted for publication in XXX (name of the journal).We notice that there is a charge for the publication of the manuscript (or for printing the color figures, or whatever you are charged). The publication fees (or costs for printing the color figures, or whatever you are charged) appear too expensive for me at the moment. Although this project was supported by a grant from ****, but the total amount of the grant was RMBXXXX (about $XXXX). With this amount, we could just mange to conduct and complete our experiments, and thus we do not have enough funding to pay for the publication fees (or for printing the color figures, or whatever you are charged).Therefore, I am writing you to explore the possibility that the publication fees (or for printing the color figures, or whatever you are charged) could be reduced or even waived. However, if you have a difficulty to offer us such a concession, we will make our every effort to meet the requirements for the publication including payment of the publication fees (or for printing the color figures, or whatever you are charged) since the publication of this paper in your journal is very important for us.Thank very much for your consideration, and look forward to hearing from you soon.With kind regards,DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisYours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this撤稿申请信(Withdrawal Request Letter)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),Re: Ms# XXXXX (number of the manuscript if any) – XXXXX (title of the article)I am writing you to inform you that we have to withdraw the abovementioned manuscript for further consideration for publication in XXXX (journal’s name), due to a technical reason (or whatever reasons or no reasons at all).I apologize for any inconvenience caused by the withdrawal of this article.Once again, thank you very much for your consideration and time.With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)Corresponding authorDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this给作者全文索取信(Reprint Request Letter to Author)(Please delete the annotations in italic in the parentheses.)Dear Dr. or Prof. XXXX (family name of the Editor or Editor-in-Chief who issued the decision letter),I am very interested in reading your article published in XXXX (name of the journal) (the full citation copied from PubMed or other data source).However, our library does not subscribe the journal. Therefore, I am writing to you to request if you could send me the reprint in pdf, or a copy of the article by email, or by postal mail. I will be also grateful if you could send all your articles relevant to the topic (add this sentence only if you really need).Thank very much in advance.With kind regards,Yours sincerely,XXXX (name of the corresponding author)XXX (title of the corresponding author)DisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this作者职责、版权转让及利益冲突声明样本(Examples for Authors Responsibility andCopyright Transfer, Declaration of Conflict of Interest)例一 Journal of Clinical GastroenterologyDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this例二 CancerDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use thetemplates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use thetemplates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this例三 GastroenterologyDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this例四 Alimentary Pharmacology & TherapeuticsDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use thetemplates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this例五 Drug SafetyDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use the templates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use thetemplates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of thisDisclaimerThe templates are prepared by Medjaden Bioscience Limited (, medjaden@) as references, for our fellow Chinese investigators to publish their research articles in English journals. Medjaden encourages authors to use thetemplates in a creative way because the situation of every article is unique and is different from each other. Copy/paste of this。
SCI论文投稿之投稿信(CoverLetter)写法--附真实案例
![SCI论文投稿之投稿信(CoverLetter)写法--附真实案例](https://img.taocdn.com/s3/m/6b0f6a3900f69e3143323968011ca300a6c3f600.png)
SCI论⽂投稿之投稿信(CoverLetter)写法--附真实案例⽂章⽬录1 Cover Letter 是什么?Cover Letter, 即投稿信,是论⽂投递时与论⽂⼀起发送给编辑的信件,其⽬的是让编辑在阅读你的论⽂之前,简单了解你⽂章的基本情况。
2 主要包含什么内容1. 期刊编辑的姓名不知道编辑是谁的情况下直接⽤ Dear editor; 但是,只要⽤⼼⼀点,去期刊官⽹查找,⼀般都能找到的。
2. 投稿⽂章的标题在以第⼀段直接给出⽂章的标题3. 投稿⽂章的类型如 Letter, communications, article, review还是comments。
这个其实也可以不写,因为在投稿时会选择投稿⽂章类型。
4. 论⽂简介简要包括研究背景,发现以及可以发表在期刊上的原因等等5. 作者信息⼀般为通讯作者姓名,所属机构,通讯地址,联系电话,邮箱等经将这⼀部分挪到了投稿⽹站系统上,Cover letter中可以不再列出)讲了这么多,分享⼀个实际的案例吧。
案例–第⼀次投稿怎么写主体内容Dear Dr. Ciaccio, 杂志主编On behalf of all coauthors, I am submitting our manuscript entitled “⽂章标题”for your consideration for publication in Biology and Medicine.我谨代表所有合著者,提交我们题为“⽂章标题”的⼿稿,供您考虑在⽣物学和医学上发表。
Although there has been a large amount of research focusing on medical image segmentation, few studies have focused specifically on the segmentation of tiny organs.The difficulty of tiny organ segmentation is that the shape varies greatly among individuals and the boundary with surrounding tissues is not clear.In the current study, we proposed a ⽅法, which successfully solves the above two difficulties. The experimental resultsshow that our proposed ⽅法 outperforms the state-of-the-art deep learning method in segmenting xxx with respect to accuracy.Another strength of our method is that it requires fewer trainable parameters and imposes a smaller demand on computational resources.The proposed method can potentially assist clinicians in diagnosis and treatment planning by quickly inspecting abnormalities in xxx and further quantitative analysis.虽然已经有⼤量的研究集中在医学图像分割上,但是很少有研究专门针对微⼩器官的分割。
sci通讯格式
![sci通讯格式](https://img.taocdn.com/s3/m/e5c83b052a160b4e767f5acfa1c7aa00b52a9db1.png)
sci通讯格式
2. 书籍: - 单个作者:Author, A. Title of the book. Publisher, Year. - 多个作者:Author1, A., Author2, B., and Author3, C. Title of the book.
1. 期刊论文: - 单个作者:Author, A. Title of the article. Journal Name, Year, Volume(Issue),
Page Range. - 多个作者:Author1, A., Author2, B., and Author3, C. Title of the article. Journal
3. 文献标题:文献标题用斜体表示,并使用句点作为结束符。
sci通讯格式
4. 期刊名称:期刊名称用斜体表示,并使用缩写形式。 5. 年份:引用的文献的发表年份。 6. 卷号和期号:引用的文献所在期刊的卷号和期号。 7. 页码:引用的文献的起始页码和结束页码。
sci通讯格式
以下是一个示例SCI通讯格式的引用文献格式:
Publisher, Year.
3. 会议论文: - 单个作者:Author, A. Title of the paper. In Proceedings of the Conference
Name, Year, Page Range. - 多个作者:Author1, A., Author2, B., and Author3, C. Title of the paper. In
Proceedings of ar, Page Range.
sci通讯格式
SCI论文发表格式规范要求【范本模板】
![SCI论文发表格式规范要求【范本模板】](https://img.taocdn.com/s3/m/9079f7e1bb68a98270fefa74.png)
SCI论文发表格式规范要求1。
SCI论文发表长度学位论文长度以能清楚、充分地论证某一论题或观点,或以恰当的视角提出问题、分析问题并能围绕解决问题提出合理化建议为最低限度。
硕士论文一般以30000字左右为宜。
2。
用纸、页面设置与打印装订论文采用A4纸,双面打印(从“中文摘要"开始);纵向版式,左侧装订.页面设置的页边距为:上、下、左、右各2。
5厘米;页码居中。
论文检测通过后三天内,需打印纸质论文一式8份(无需硬质封面)送交院教研办,以用于交叉评阅和论文答辩用稿。
论文答辩通过后三天内,论文统一装订后由指导教师在指定栏目内手写签名,一式8份送交院教研办(其中2本交研究生处,2本交院资料室,1本送图书馆,1本送校综合档案室及院教研办留存);另外须将论文电子版通过网络提交到学校图书馆。
3。
SCI论文发表组成部分(1)封面(格式统一,可修改套用);(2)英文封内页(格式统一,可修改套用);(3)原创性声明和使用授权说明(格式统一,可修改套用);(4)中文摘要;(5)英文摘要;(6)目录;(7)正文;(8)参考文献;(9)作者在读期间科研成果简介;(10)后记4.SCI论文发表格式要求与写作规范(请参考期刊vip上的论文范文)(1)题目:题目应能概括整个论文最重要的内容、简明、恰当,引人注目,力求简短,一般不宜超过20字,可用小标题加以说明。
(2)中文摘要与关键词:论文摘要是学位论文的缩影,应以精练、准确的语言,说明本论文的选题价值、写作目的、主要观点、研究方法等,要突出本论文的创造性成果或新见解。
尽可能地保留论文的基本信息.标题“摘要"设置成字体:黑体,水平居中对齐;字号:三号;行距:固定值20磅;段前、段后均为自动。
摘要内容每段落首行缩进2个汉字;字体:宋体;字号:小四;行距:固定值20磅;段前、段后均为0行,取消网格对齐选项。
摘要正文后,列出3—8个关键词。
关键词与内容摘要之间空一行。
sci 参考文献格式
![sci 参考文献格式](https://img.taocdn.com/s3/m/b4bbfd9432d4b14e852458fb770bf78a65293a28.png)
sci 参考文献格式SCI(Science Citation Index)是科学引文索引,是一种常用的学术文献引用格式。
SCI参考文献格式主要遵循以下几个方面的要求:1. 作者格式,作者姓名一般按照姓氏在前,名字在后的顺序排列,中间用逗号隔开。
如果有多个作者,每个作者之间用逗号隔开,最后一个作者前用英文“and”连接。
2. 文章标题格式,文章标题一般使用双引号括起来,并且只有首字母大写,除非标题中包含专有名词或缩写。
3. 期刊名称格式,期刊名称一般使用斜体字,并且缩写为期刊的标准缩写形式。
4. 文章发表年份格式,文章的发表年份一般紧随作者姓名之后,用括号括起来。
年份后面加上逗号。
5. 文章卷号、期号和页码格式,文章的卷号和期号一般在发表年份之后,用括号括起来,并且用逗号隔开。
页码一般在卷号和期号之后,用冒号隔开。
6. DOI格式,DOI(Digital Object Identifier)是文章的数字对象标识符,一般在参考文献中提供DOI可以帮助读者更方便地找到文章。
DOI一般在文章的页码之后给出,并且前面加上“doi:”字样。
以下是一个SCI参考文献的示例格式:作者. 文章标题. 期刊名称, 发表年份, 卷号(期号): 页码. DOI.例如:Smith, J., Johnson, A. B., & Brown, C. D. "The effectsof climate change on biodiversity." Science, 2020,367(6479): eaax3100. doi: 10.1126/science.aax3100.需要注意的是,SCI参考文献格式可能会根据不同的期刊和出版社的要求有所差异,因此在撰写参考文献时,最好参考目标期刊的官方指南或要求,以确保格式的准确性和一致性。
sci的基本格式
![sci的基本格式](https://img.taocdn.com/s3/m/99f9666a2e60ddccda38376baf1ffc4ffe47e2a0.png)
sci的基本格式如下:
•字体:一般选用Arial格式或者Times New Roman 格式。
•字号:不同期刊有不同要求,一般为小四号字体或者10号字体。
•字数:很多期刊对文章字数没有要求,但也有期刊会对字数有限制要求,有的要求不超过4500字或者5000字。
•不同层级的标题表示:注意是否加粗,字体是否有要求,标题的大小写。
•斜体:个别的统计相关的字符或者拉丁学名要用斜体表示。
•其他:注意期刊的要求,具体每个期刊对格式的要求都有区别,首先登录期刊投稿页面,找到如For authors、Information for authors、Guide for author等选择菜单栏,找到目标期刊的投稿
须知,认真阅读,然后根据要求一条条修正。
sci的论文格式
![sci的论文格式](https://img.taocdn.com/s3/m/640d8c1aad51f01dc381f12a.png)
sci的论文格式sci的论文格式导语:SCI论文成功发表,其中SCI论文格式十分重要,一篇优秀的论文不仅内容上要有价值与创新,其排版格式也要符合规范,SCI论文主要包括3个部分,即前置部分、主题部分和附录部分,其排版先后顺序与具体格式要求如下,下面小编整理了sci的论文格式,欢迎参考借鉴!前置部分包括①题目(title);②作者(单位及/或个人姓名);③内容摘要(Summary);④关键词(keywords)。
主题部分包括⑤前言(introduction);⑥材料与方法(materi-alsandmethods);⑦结果(results);⑧讨论(disscussion);⑨结论(conclusion);⑩致谢(thanks)、参考文献(references)、完成论文或投稿日期、外文摘要。
附录部分包括图(chart)、表(table)、照片(photoshop)等。
格式并非一成不变,作者应根据文稿的内容、体裁及篇幅的长短撰写,切记不要硬套格式。
篇幅小的论文,可将前言、材料与方法两项合并,讨论与结论合并,并省去“内容摘要(Summary)”.有协作关系或得到有关单位个人支持帮助的,要在首页注脚处加一项“致谢(thanks)”.SCI论文字体、段落格式:纸张大小标准的8.5英寸x11英寸纸张大小。
页边距上下左右页边距都为1寸英。
字体12号字体大小。
Times Roman.但是图片使用无衬线字体,如Arial。
行距两倍行距。
对齐方式左对齐(右边距不相等)。
段落缩进5-7个空格。
句末句号后一个空格。
页码标题页开始,除图片页外每一页的右上角,离顶部0.5英寸处标上页码,右对齐。
标题页标题页通常是第一页。
在页码下一行,副标题左对齐,副标题要全部大写。
在副标题下,使用大写和小写表示以下内容,居中对齐。
文章标题你的名字你所属的机构信息。
段落标题一级标题使用大小写字母,并且居中。
二级标题使用大小写字母,左对齐。
sci文章格式要求
![sci文章格式要求](https://img.taocdn.com/s3/m/44bd28f868dc5022aaea998fcc22bcd126ff42de.png)
sci文章格式要求
SCI(Science Citation Index)是科学引文索引,一般是指被SCI收录的学术期刊。
SCI文章的格式要求主要取决于特定期刊的投稿规定,因为每个期刊都有自己的格式和规范。
以下是一般来说,SCI期刊可能要求的一些通用的文章格式要求:
1.标题页(Title Page):
•文章标题
•所有作者的姓名和机构
•通讯作者的联系信息
•摘要和关键词
2.正文(Main Text):
•引言:研究的背景、目的、假设或问题。
•方法:详细说明研究设计、实验过程、数据收集和分析方法。
•结果:呈现研究的主要发现,通常包括图表和表格。
•讨论:对结果进行解释、比较、分析,并讨论其在领域中的意义。
•结论:总结研究的主要结论和可能的未来研究方向。
3.引用(References):
•列出文章中引用的所有文献。
引用格式可能要求符合特定的引文风格,如APA、MLA或Chicago等。
4.图表和表格(Figures and Tables):
•图表和表格通常需要有清晰的标题和编号,以及必要的说明文字。
5.文献引用格式:
•引文一般要求按照特定的引文风格进行,例如,按作者-年份格式或使用数字编号。
6.稿件提交要求:
•包括稿件的文件格式(通常要求使用Word或LaTeX)、图表的分辨率和格式要求等。
请注意,以上只是一般性的指导,具体的要求可能会因期刊而异。
在准备投稿SCI期刊时,务必仔细查阅目标期刊的官方投稿指南或作者指南,以确保符合特定期刊的格式和规范。
这些信息通常可以在期刊的官方网站上找到。
SCI论文投稿信写作模板
![SCI论文投稿信写作模板](https://img.taocdn.com/s3/m/34008371bcd126fff7050be7.png)
SCI论文投稿信写作模板当选定了拟投期刊和论文的最后一稿准备好后,就可向SCI期刊投稿了。
但是有很多小伙伴不知道投稿信怎么写,那今天小编就奉上几个写作模板,希望能够帮助到大家。
投稿信范例1Dear Editor,Enclosed for your consideration is an original research articl,entitled“××××”1. All authors of this research paper have direct Ly participated in the planning execution, or analysis of this study2. All authors of this paper have read and approved the final version submitted.3. The contents of this manu have not been copyrighted or published previously.4. The contents of this manuscri pt are not nowe under consideration for publication elsewhere.5. The contents of this manu will not be copyrighted, submitted,or published elsewhere while acce ptance by the Journal is under consideration.6. There are no directly related manus or abstracts,published or unplished, by any authors of this paper.We believe the paper may be of particular interest to the readers of your journal because the study reports that...Correspondence and phone calls about the paper should be directed to at the following address, phone and fax number, and e-mail adress:(your name and address here)Thanks very much for your attention to our paper.Sincerely yours(your name here)投稿信范例-2Dear Dr.××××,I would like to submit the attached manu,“××××”for considerati on for possible publication in the Research Articles section of SCIMy two nominees for associate editor are Dr. Smith and Dr.××××,Dr.Smith is well versed in the topic of the paper while Dr.×××× has used a methodology in his own research that is related to the methodology in the paper being submitted.Regarding the option of nominating up tofour reviewers, my nominees are:Name-1, Email address-1Name-2, Email address-2Name-3, Email address-3Name-4, Email address-4The nominees for associate editor and reviewers have no conf lict of in terest with any of the authors of the paper being submitted.This paper(or closely related research) has not been published or accepted for publication. It is not under consideration at another journal.No other papers using the same data set have been published. ( Note: If other papers using the data set have been published, please indicate differences between the submitted paper and the other published papers.)Sincerelyyour name and address hereOK,大家是不是觉得还是有点无从下手的感觉?小编也是非常理解大家的,毕竟,英语对于咱们中国人来说,可不是短期内就能up up up的。
SCI期刊格式要求及建议
![SCI期刊格式要求及建议](https://img.taocdn.com/s3/m/5371cce504a1b0717fd5ddbc.png)
1. 一般避免使用人称代词。
使用被动语态来描述作者所做的动作(例如,“测试已经完成”,“这项工作的核心假设已经在5级洁净室中进行了测试”)。
这是为了强调和鼓励科学工作的客观性在期刊上发表。
2. 在描述实验方法和结果(例如,“所有吸收光谱在Model XXX HP二极管阵列分光光度计上收集”)时,通常使用过去时态。
原因是我们希望读者能够非常清楚地知道文章的哪些部分代表着作者的工作。
3. 在“介绍”和在一个给定的领域的讨论,描述的科学知识的艺术状态,现在时态的使用感兴趣。
例如,如果研究人员达成共识,则可能有以下推测性陈述:“化合物X处理后,纤维素在水中的溶解度高于化合物Y(Smith,1997; Chu等,1999)。
例外,如果过去有明确的做法,例如“Jones和El-Akhbar(1992)早些时候报道矛盾的发现。
4. 新作者经常不重视讨论他们的结果。
特别是,比较和比较你的新结果和其他人以往的理论和经验工作,通常是一个好主意。
根据作者的偏好,提交给BioResources的作者可以结合“结果和讨论”或使用单独的“结果”和“讨论”部分。
在任何一种情况下,科学出版物的最大价值都涉及分析,解释或证明你的结果与一个或多个假设有关的努力。
5. 在编写实验部分时,要遵循的主要标准是,未来的其他研究人员应该能够重复您的工作。
只是引用你所遵循的已发布的程序,这是完全令人满意的。
但是,您需要认真解释您自己的研究独有的任何程序。
在某些情况下,根据工作的新颖性或其他考虑,在本节中更为全面可能是有意义的。
应为本节中提到的所有专用试剂,设备和软件提供制造商名称和位置。
应该引用所有的标准和方法。
6. 在撰写“导论”时,新作者应该根据文献重点提供充分的背景知识,以便对本领域有些陌生的读者能够判断其新发现的相对重要性。
应该强调当前工作所依赖的重要文章。
在一篇研究文章(与一篇评论文章相对)中,没有必要对已经在其他出版物中解释过的概念或事实进行广泛的解释。
SCI英文投稿信件的八股格式
![SCI英文投稿信件的八股格式](https://img.taocdn.com/s3/m/fb7fbd00e87101f69e319544.png)
以下是英文投稿过程中的十种状态和需要注意的问题:1. Submitted to Journal当上传结束后,显示的状态是Submitted to Journal,这个状态是自然形成的无需处理。
2. With editor如果在投稿的时候没有要求选择编辑,就先到主编那里,主编会分派给别的编辑。
这当中就会有另两个状态:①Editor assigned编辑分派②Editor Declined Invitation编辑拒绝邀请,这时主编不得不将投稿文章重新分派给其它编辑。
3. Reviewer(s) invited说明编辑已接手处理,正在邀请审稿人中。
有时该过程会持续很长时间,如果其中原因是编辑一直没有找到合适的审稿人,这时投稿者可以向编辑推荐审稿人。
4. Under review审稿人的意见已上传,说明审稿人已接受审稿,正在审稿中,这应该是一个漫长的等待(期刊通常会限定审稿人审稿时间,一般为一个月左右)。
当然前面各步骤也可能很慢的,要看编辑的处理情况。
如果被邀请审稿人不想审,就会decline,编辑会重新邀请别的审稿人。
5. required review completed审稿结束,等编辑处理,该过程短则几天,长则无期,科学堂有一篇文章出现required review completed状态已近一个月了,还是没有消息。
6. Decision in Process到了这一步就快要有结果了,编辑开始考虑是给修改还是直接拒,当然也有可能直接接受的,但可能性很小,呵呵。
7. Minor revision/Major revision小修/大修,这个时候可以稍微庆祝一下了,因为有修改就有可能。
具体怎么改就不多说了,谦虚谨慎是不可少的(因为修改后一般会再发给审稿人看,所以一定要细心的回答每一个审稿人的每一个问题,态度要谦逊,要让审稿人觉得他提的每个问题都很有水准的,然后针对他的问题,一个一个的做出答复,能修改的就修改,不能修改的给出理由,而且都要列出来,文章的哪一段哪一行修改了最好都说出来,记住:给审稿人减少麻烦就是给你自己减少麻烦!另注:有时,审稿人会在修改意见里隐讳里说出要你仔细阅读某几篇文献,这时可要注意了,其中某些文章可能就是评审者自己发表的,这时你最好在你的修改稿中加以引用),修改后被拒绝的例子也多不胜数的。